South Korea courts high-tech investment:
This article was originally published in Clinica
Executive Summary
South Korea has halved the tax-exemption threshold of investment by foreign manufacturers to $50 million. Business income and dividends will be exempted for the first seven years and subject to half the normal rate over the following three. Similar incentives apply to other taxes over the same periods. Distribution activities involving foreign investments of at least $30 million will also qualify for such incentives. The country is keen to attract investment especially in high-technology sectors.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.